Fresenius | FRE - Operating Expenses

Stock Price
46.93
Daily Change
0.11 0.22%
Monthly
-9.97%
Yearly
17.55%
Q1 Forecast
45.46

Fresenius reported EUR5.25B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Akzo Nobel EUR 2.16B 95M Dec/2025
Alcon AG USD 2.41B 123M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 14.21B 372M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Beiersdorf EUR 4.16B 212M Dec/2025
DaVita Healthcare Partners USD 3.04B 3.61B Dec/2025
Demant DKK 9.63B 241M Dec/2025
E.ON EUR 20.13B 4.41B Dec/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Getinge SEK 9.99B 2.3B Dec/2024
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GN Store Nord DKK 4.11B 490M Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
RWE EUR 2.32B 715M Sep/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025